Nypozi Injection
Product Images NDC 69097-430

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Nypozi (NDC 69097-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

300mcg (1) 0.5 mL Syringe Carton. (300mcg (1) 0.5 mL Syringe Carton)

This text appears to be a description of a pharmaceutical product called NYPOZI™ Single-Dose Prefilled Syringe, which contains the medication filgrastim-txid in the form of an injection. The product is a Recombinant Granulocyte Colony Stimulating Factor derived from E. Coli, intended for subcutaneous or intravenous use. Instructions are given on how to dilute the medication for intravenous administration and under what conditions the product should be stored. The manufacturer is Tanvex BioPharma USA, Inc. from San Diego, CA. The product is indicated to be refrigerated and kept away from light. It is also mentioned to be kept out of reach of children.*

FDA Label Image

300mcg (10) 0.5 mL Syringe Carton. (300mcg (10) 0.5 mL Syringe Carton)

FDA Label Image

480mcg (1) 0.8 mL Syringe Carton. (480mcg (1) 0.8 mL Syringe Carton)

This text provides information about a single-dose prefilled syringe named NYPOZI™ containing filgrastim-txid injection with a concentration of 480 mcg/0.8 mL. It is a recombinant Granulocyte Colony Stimulating Factor (G-CSF) derived from E. Coli and is recommended for subcutaneous or intravenous use. For intravenous administration, it should be diluted in 5% Dextrose Injection, and if needed, Albumin (Human) should be added. The syringe should be discarded after use. The product does not contain latex, and it is stored refrigerated between 2 to 8 degrees Celsius. The text also mentions the manufacturer Cipla and provides contact information. It emphasizes keeping the drug out of reach of children and includes dosing information.*

FDA Label Image

480mcg (10) 0.8 mL Syringe Carton. (480mcg (10) 0.8 mL Syringe Carton)

FDA Label Image

Cipla Logo. (Cipla Logo)

FDA Label Image

Nypozi-01. (Nypozi 01)

This text seems to be describing the components and instructions for using a medical product, likely a syringe. It includes details such as the viewing window, expiration date label, needle guard, finger grips, plunger, dose markings, and instructions for before and after use. This information may be helpful for understanding how to properly operate and maintain the syringe.*

FDA Label Image

Nypozi-02. (Nypozi 02)

FDA Label Image

Nypozi-03. (Nypozi 03)

FDA Label Image

Nypozi-04. (Nypozi 04)

FDA Label Image

Nypozi-05. (Nypozi 05)

This is a list of medical supplies that includes alcohol wipes, adhesive bandages, and a disposal container. The alcohol wipes can be used for cleaning wounds, while adhesive bandages are used to cover small cuts or injuries. The disposal container is likely for safe disposal of used medical supplies.*

FDA Label Image

Nypozi-06. (Nypozi 06)

FDA Label Image

Nypozi-07. (Nypozi 07)

FDA Label Image

Nypozi-08. (Nypozi 08)

FDA Label Image

Nypozi-09. (Nypozi 09)

FDA Label Image

Nypozi-10. (Nypozi 10)

This text seems to describe a step-by-step process for setting a partial dose. It includes instructions for the initial position and aligning the plunger stopper for the dose.*

FDA Label Image

Nypozi-11. (Nypozi 11)

FDA Label Image

Nypozi-12. (Nypozi 12)

FDA Label Image

Nypozi-13. (Nypozi 13)

FDA Label Image

Nypozi-14. (Nypozi 14)

FDA Label Image

Nypozi-15. (Nypozi 15)

FDA Label Image

Nypozi-16. (Nypozi 16)

FDA Label Image

Nypozi-17. (Nypozi 17)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.